Ubs Group Ag Abb Vie Inc. Transaction History

Ubs Group Ag

$397 Billion
Q1 2024

A detailed history of Ubs Group Ag transactions in Abb Vie Inc. stock. As of the latest transaction made, Ubs Group Ag holds 709,300 shares of ABBV stock, worth $114 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

709,300

Previous 10,905,122 93.5%

Holding current value

$114 Million

Previous $1.69 Billion 92.36%

% of portfolio

0.03%

Previous 0.51%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $63.4 Million - $72.3 Million	-396,913 Reduced 3.64%	10,508,209 $1.91 Billion
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $47.5 Million - $53.5 Million	345,137 Added 3.27%	10,905,122 $1.69 Billion
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $73.6 Million - $85.2 Million	-551,084 Reduced 4.96%	10,559,985 $1.57 Billion
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $28.3 Million - $35.3 Million	213,830 Added 1.96%	11,111,069 $1.5 Billion
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $12.8 Million - $14.7 Million	88,432 Added 0.82%	10,897,239 $1.74 Billion

Q4 2022 Feb 08, 2023	BUY	$138.31 - $165.87 $130 Million - $156 Million	939,799 Added 9.52%	10,808,807 $1.75 Billion
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $15.7 Million - $18 Million	116,678 Added 1.2%	9,869,008 $1.32 Billion
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $83.2 Million - $106 Million	604,659 Added 6.61%	9,752,330 $1.49 Billion
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $75.7 Million - $94 Million	-573,850 Reduced 5.9%	9,147,671 $1.48 Billion
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $6.73 Million - $8.51 Million	62,634 Added 0.65%	9,721,521 $1.32 Billion
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $2.24 Million - $2.55 Million	21,075 Added 0.22%	9,658,887 $1.04 Billion
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $41.9 Million - $46.7 Million	398,307 Added 4.31%	9,637,812 $1.09 Billion
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $32.4 Million - $35.6 Million	-316,343 Reduced 3.31%	9,239,505 $1 Billion
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $71.1 Million - $96 Million	883,025 Added 10.18%	9,555,848 $1.02 Billion
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $74.6 Million - $87.6 Million	868,655 Added 11.13%	8,672,823 $760 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $109 Million - $145 Million	1,478,977 Added 23.38%	7,804,168 $766 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $49.3 Million - $74.8 Million	764,906 Added 13.76%	6,325,191 $482 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $29.2 Million - $36.6 Million	405,020 Added 7.86%	5,560,285 $492 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $52.9 Million - $63.6 Million	-839,964 Reduced 14.01%	5,155,265 $390 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $14 Million - $17.9 Million	-212,821 Reduced 3.43%	5,995,229 $436 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $32.4 Million - $38.2 Million	420,356 Added 7.26%	6,208,050 $500 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $66 Million - $81.4 Million	-848,068 Reduced 12.78%	5,787,694 $534 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $54.2 Million - $60.2 Million	-609,090 Reduced 8.41%	6,635,762 $628 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $47.3 Million - $56 Million	527,218 Added 7.85%	7,244,852 $671 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $109 Million - $146 Million	-1,183,562 Reduced 14.98%	6,717,634 $636 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $6.64 Million - $7.28 Million	-74,161 Reduced 0.93%	7,901,196 $764 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $31.2 Million - $39.9 Million	-446,930 Reduced 5.31%	7,975,357 $709 Million
Q2 2017 Aug 14, 2017	BUY	N/A	518,997 Added 6.57%	8,422,287 $611 Million
Q1 2017 Nov 14, 2017	BUY	N/A	7,903,290	7,903,290 $515 Million

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account